This is a preview of subscription content, log in via an institution to check access.
References
Farr S, McElduff A, Ward E, et al. A comparison of the pharmacokinetics and pharmacodynamics of inhaled insulin administered as different strength solutions to healthy volunteers. Diabetes 1998 May; 47 Suppl. 1: 61
Laube BL, Benedict GW, Dobs AS. The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes. Chest 1998 Dec; 114: 1734–9
Aradigm shows inhaled insulin may allow diabetics to control meal-time glucose levels control over breathing may be key to achieving reproducible delivery of inhaled insulin. PR Newswire [online]. Available from: URL: http://www.newspage.com [Accessed 1997 Apr 29]
Kipnes M, Otulana B, Clauson P, et al. A comparison of the pharmacodynamic effects of inhaled insulin versus subcutaneous insulin in type 1 diabetic patients. Diabetes 1999 May; 48 Suppl. 1: 95
Aradigm Corporation. Electronic insulin inhaler shows faster reduction of blood glucose than injections. Clinical trials find AERx (Rm) system delivers insulin more rapidly [media release]. Hayward (CA): Aradigm Corporation, 1998 Jun 17
Rights and permissions
About this article
Cite this article
Insulin Inhalation (Aradigm Corporation). Drugs R&D 2, 110–111 (1999). https://doi.org/10.2165/00126839-199902020-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-199902020-00006